Histocompatibility Typing.

Abstract

Major qualitative and quantitative improvements have been made in HLA-D typing. These improvements include advances in homozygous typing cell typing, primed lymphocyte typing and the utilization of these reagents and methods in parallel test systems. First the efficiency of performing and analyzing homozygous typing cell (HTC) experiments has been increased. Second, additional homozygous typing cells of both known specificity and previously undefined type have been obtained. The selection of this laboratory as one of fourteen major HLA-D typing laboratories by the Eighth International Histocompatibility Workshop demonstrates our current international recognition and will assure our continued leadership in this area. Several important developments in primed lymphocyte typing (PLT) have been made. Finally the techniques and reagents developed have led to advances in parallel research areas. Homozygous typing cells and HLA-D typed panel were used to determine the association of certain HLA specificities and level of peripheral blood cytotoxic lymphocytes. The primed lymphocytes technique has been used to identify a new potential role for interferon in clinical transplantation. Homozygous typing cells have been transformed into B-cell lines for use as standard reagents in the identification of B-cell antisera.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Jun 15, 1979
Accession Number
ADA071145

Entities

People

  • Paula Romano
  • Philip L. Calcagno

Organizations

  • Georgetown University

Tags

DTIC Thesaurus Topics

  • Abstracts
  • B Lymphocytes
  • Biomedical Research
  • Blood
  • Bone Marrow
  • Cell Line
  • Cells
  • Computers
  • Culture Media
  • Genetics
  • Health Services
  • Hematologic Diseases
  • Lymphocytes
  • Medical Personnel
  • Navy
  • Tissue Donors
  • Transplants

Fields of Study

  • Biology

Readers

  • Immunology
  • Molecular Genetics
  • Systems Analysis and Design

Technology Areas

  • Biotechnology
  • Biotechnology - Cancer Biotech